- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Brawn Biotech's Board of Directors has approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs. 5.80 Cr. Notably, Brawn Biotech achieved a profit of Rs. 0.24 Cr for the period, a significant turnaround from previous losses. Basic earnings per share stood at Rs. 0.89. These results provide key insights into the company's recent operational performance and financial health for shareholders.